Tonix Pharmaceuticals Holding short interest in 2023
In 2023, Tonix Pharmaceuticals Holding's disclosed short interest ran from 9.83% of shares outstanding on 13 Jan 2023 to 0.42% on 15 Nov 2023, a change of -9.41 percentage points. The year's high was 9.83% on 13 Jan 2023 and its low 0.42% on 15 Nov 2023, averaging 3.72% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.55 days on 31 Mar 2023. Full history: Tonix Pharmaceuticals Holding.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2025 · 2026
2023 in figures
- Start of year
- 9.83% (13 Jan 2023)
- End of year
- 0.42% (15 Nov 2023)
- Change
- -9.41 pp
- High
- 9.83% (13 Jan 2023)
- Low
- 0.42% (15 Nov 2023)
- Average
- 3.72%
- Highest days to cover
- 3.55 (31 Mar 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 9.83% | 1.00 | |
| 31 Jan 2023 | 7.39% | 1.00 | results (8-K) |
| 15 Feb 2023 | 6.30% | 1.84 | |
| 28 Feb 2023 | 4.61% | 1.39 | |
| 15 Mar 2023 | 4.91% | 2.10 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 4.01% | 3.55 | |
| 14 Apr 2023 | 2.32% | 2.51 | |
| 28 Apr 2023 | 2.39% | 1.85 | |
| 15 Aug 2023 | 2.58% | 1.00 | 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Aug 2023 | 1.72% | 1.75 | |
| 29 Sep 2023 | 2.24% | 1.00 | |
| 13 Oct 2023 | 1.54% | 1.00 | |
| 31 Oct 2023 | 1.87% | 1.22 | |
| 15 Nov 2023 | 0.42% | 1.00 | 10-Q filed, results (8-K) |
See also: Tonix Pharmaceuticals Holding's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.